Legend Biotech Corporation (LEGN)
NASDAQ: LEGN · Real-Time Price · USD
40.94
+1.19 (2.99%)
Nov 22, 2024, 4:00 PM EST - Market closed
Legend Biotech Stock Forecast
Stock Price Forecast
The 13 analysts with 12-month price forecasts for Legend Biotech stock have an average target of 81.46, with a low estimate of 60 and a high estimate of 94. The average target predicts an increase of 98.97% from the current stock price of 40.94.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Legend Biotech stock from 13 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 5 | 5 | 5 | 6 | 6 |
| Buy | 7 | 8 | 7 | 7 | 7 | 7 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 13 | 12 | 12 | 13 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $73 | Strong Buy | Reiterates | $73 | +78.31% | Nov 13, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $86 | Buy | Reiterates | $86 | +110.06% | Oct 29, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $73 | Strong Buy | Reiterates | $73 | +78.31% | Oct 16, 2024 |
| Redburn Atlantic | Redburn Atlantic | Strong Buy Initiates $86 | Strong Buy | Initiates | $86 | +110.06% | Oct 8, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $73 | Strong Buy | Reiterates | $73 | +78.31% | Oct 4, 2024 |
Financial Forecast
Revenue This Year
598.91M
from 285.14M
Increased by 110.04%
Revenue Next Year
1.06B
from 598.91M
Increased by 77.16%
EPS This Year
-1.09
from -2.94
EPS Next Year
-0.68
from -1.09
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 687.0M | 1.4B | 2.3B | ||
| Avg | 598.9M | 1.1B | 1.7B | ||
| Low | 454.6M | 824.6M | 1.2B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 140.9% | 129.9% | 115.4% | ||
| Avg | 110.0% | 77.2% | 56.6% | ||
| Low | 59.4% | 37.7% | 13.5% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.51 | 0.40 | 1.72 | ||
| Avg | -1.09 | -0.68 | 0.51 | ||
| Low | -1.68 | -1.60 | -0.04 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.